IL17A and Alzheimer disease: The GO/KEGG enrichment results indicated that anti-AD and anti-rosacea effects exerted by MLT were directed via regulating vascular-associated signaling pathways and inflammation-related signaling pathways, including IL-17, NF-κB, and TNF.